Yasuto Naoi

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<scp>GSTP</scp>1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in <scp>ER</scp>‐negative breast cancer

Tomohiro Miyake, Takahiro Nakayama, Yasuto Naoi et al. · Cancer Science · 2012 · 149 citations · Full text

Medicine, Oncology, Pharmacology +17

PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients

Chiya Oshiro, Naofumi Kagara, Yasuto Naoi et al. · Breast Cancer Research and Treatment · 2015 · 144 citations

Medicine, Genetics, Oncology +14

Correlation of Methylated Circulating Tumor DNA With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Hiroyo Takahashi, Naofumi Kagara, Tomonori Tanei et al. · Clinical Breast Cancer · 2016 · 86 citations

Medicine, Cancer Biology, Oncology +16

Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer

Yasuto Naoi, Yasuo Miyoshi, Tetsuya Taguchi et al. · Breast Cancer Research and Treatment · 2007 · 85 citations

Medicine, Cancer Biology, Oncology +14